Abstract
Aim: To evaluate the safety and efficacy of sedation/analgesia administered solely by the treating urologist during minimally invasive transurethral procedures. Methods: All patients who underwent minimally invasive transurethral procedures under sedation/analgesia delivered solely by the treating urologist were analyzed. They all received intravenous midazolam, and some also received ketamine according to the discretion of the urologist. Results: The 77 study patients uneventfully underwent insertion of an internal ureteral stent (n=30), cystoscopy (n=26), cold cup biopsies of bladder tumors (n=19), and urethral dilations (n=2). Conclusion: Sedation/analgesia administered solely by the treating urologist during minimally invasive transurethral procedures is safe and effective.
| Original language | English |
|---|---|
| Pages (from-to) | 74-77 |
| Number of pages | 4 |
| Journal | Ambulatory Surgery |
| Volume | 23 |
| Issue number | 3 |
| State | Published - 2017 |
Keywords
- Efficacy
- Safety
- Sedation
- Transurethral procedures